Assessing the Immunogenicity of Biopharmaceuticals

Biopharmaceuticals have the potential to raise an immunogenic response in treated individuals, which may impact the efficacy and safety profile of these drugs. As a result, it is essential to evaluate immunogenicity throughout the different phases of the clinical development of a biopharmaceutical,...

Descripción completa

Detalles Bibliográficos
Autores principales: Pineda, Carlos, Castañeda Hernández, Gilberto, Jacobs, Ira A., Alvarez, Daniel F., Carini, Claudio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4875071/
https://www.ncbi.nlm.nih.gov/pubmed/27097915
http://dx.doi.org/10.1007/s40259-016-0174-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4875071/
https://www.ncbi.nlm.nih.gov/pubmed/27097915
http://dx.doi.org/10.1007/s40259-016-0174-5

Ejemplares similares